I’ve heard the commercial on the radio about a hundred times: “At Centra Care, it’s all about you.” Until recently, I had not had the chance to verify that claim — although I had my doubts about any m...
A controversial update to the heart guidelines from the nation’s leading cardiovascular organizations could lead to doctors doubling prescriptions for cholesterol-fighting drugs, which may increase th...
Johnson & Johnson’s lawyers proposed another settlement offer in an attempt to settle thousands of DePuy ASR hip implant lawsuits filed by people injured by the device. The company will pay approximat...
Johnson & Johnson returned to an Ohio courtroom Tuesday to discuss resolution of cases involving its recalled ASR hip implants. Court records show U.S. District Judge David A. Katz, of the Northern Di...
In one of the country’s largest health care-related settlements, pharmaceutical giant Johnson & Johnson paid $2.2 billion to settle charges of false marketing, and paying doctors and nursing homes kic...
A U.K. government agency is taking a stand against one particularly controversial hip implant that has reportedly caused widespread medical complications in patients around the world. High failure rat...
A once-obscure tax on medical devices, that is part of the Affordable Care Act, turned into a major issue in the spending battle when the U.S. government shut down earlier this month. One of the amend...
When I visit my doctor, she comes into the examination room ready for battle. I research and write about drugs and medical devices for a living — my doctor knows this. She usually tries to put me at e...
After a two-week delay, the first federal trial over Johnson & Johnson’s recalled ASR hip implants is set to begin Monday, Sept. 23, in an Ohio courtroom. The case, brought by 58-year-old Ann McCracke...
Notable manufacturers of many dangerous drugs and medical devices have reported a variety of earnings results for their most recent quarters. While Stryker Corp. reported a 34 percent drop in total ne...
